Candel Therapeutics, Inc. - Common Stock, $0.01 par value (CADL)

CUSIP: 137404109

Q3 2021 13F Holders as of 30 Sep 2021

Security type / class
Equity / Common Stock, $0.01 par value
Total 13F shares
4,884,284
Total 13F value
$52,945,000
Holder snapshot 5 signals
Share change
+4,072,547
SEC-reported price per share
$10.84
Number of holders
12
Value change
+$44,146,000
Number of buys
11
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
72,977,477

Security key

137404109

Report period

Q3 2021

Institutions

12

Top holders

10

CADL full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2021 Candel Therapeutics, Inc. SEC filings Candel Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CADL - Candel Therapeutics, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Udi Meirav
Disclosed value leader
Udi Meirav
Comparable rows
0/3
Latest evidence
29 Jul 2021
3/4/5 Highest disclosed value: $43,940 3 rows are not safely comparable across share classes.

Quick read

Udi Meirav has the largest disclosed position value at $43.9K.

0 of 3 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Udi Meirav's linked filing trail.
Disclosed position value Top 3
Udi Meirav $43.9K
SMITH ALAN E $29.3K
Nathan Caffo $5.4K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-3 of 3 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Udi Meirav
3/4/5
Director
3/4/5
—
class O/S missing
$43,940
48,822 shares
 — 26 Jul 2021
SMITH ALAN E
3/4/5
Director
3/4/5
—
class O/S missing
$29,293
32,548 shares
 — 26 Jul 2021
Nathan Caffo
3/4/5
Chief Business Officer
3/4/5
—
class O/S missing
$5,400
6,000 shares
 — 29 Jul 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
12
Shares
4,884,284
Rows available
12
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q4 2025 Across Filers

Q4 2025 holders
84
Q3 2021 holders
12
Holder diff
-72
Investor Q4 2025 Shares Q3 2021 Shares Share Diff Share Chg % Q4 2025 value Q3 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .